课题基金 / 基金详情

Intrahepatic microRNA expression and response to peginterferon-α and ribavirin therapy in patients with chronic hepatitis C

Intrahepatic microRNA expression and response to peginterferon-α and ribavirin therapy in patients with chronic hepatitis C
慢性丙型肝炎患者肝内 microRNA 表达及对聚乙二醇干扰素-α 和利巴韦林治疗的反应
批准号:
21590856
负责人:
ENOMOTO Masaru
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

ENOMOTO Masaru的其他基金

相似基金

相关文献

中文摘要
翻译
利用基因芯片技术对丙型肝炎病毒(HCV)感染的人肝脏中受调控的microRNAs进行鉴定。在人肝组织中,miR-422a表达下调,miR-199a-5p/199a-3p和miR-221/222表达上调,且呈纤维化进展相关。用实时荧光定量RT-PCR检测其表达情况。在这些miRNAs中,miR-222在两种纤维化模型的小鼠肝脏中增加。在培养的星状细胞LX-2中,miR-222的表达上调,并且在小鼠原代星状细胞依赖培养激活的过程中表达增加。NF-κB抑制剂可显著抑制α或α对培养细胞的诱导作用。虽然miR-222的过度表达或下调不能调节LX-2细胞的生长,但miR-222可与p27^<Kip1>3‘非编码区结合并调节相应蛋白的表达。瞬时转染组α-1(I)胶原蛋白表达明显上调,MMP1mRNA表达明显下调。结论:miR-222可能是星状细胞活化和肝纤维化进展的新标记物。
英文摘要
The regulated microRNAs(miRNAs) in human livers infected with hepatitis C virus(HCV) were identified by microarray analysis. MiR-422a was down-regulated, and miR-199a-5p/199a-3p and miR-221/222 up-regulated in the human liver in a fibrosis progression-dependent manner. Their expression was validated by real-time RT-PCR. Among these miRNAs, miR-222 increased in mouse livers from two fibrosis models. The expression of miR-222 was up-regulated in cultured stellate cells LX-2 and increased during the course of culture-dependent activation of mouse primary stellate cells. NF-κB inhibitor significantly suppressed the miR-222 induction that was stimulated in culture by TNF-α or TGF-α. Although over-expression or down-regulation of miR-222 failed to regulate the growth of LX-2 cells, miR-222 bound to the p27^<Kip1> 3'UTR and regulated the expression of the corresponding protein. Transient transfection with miR-222 precursors significantly up-regulated α1(I) collagen and down-regulated MMP-1 mRNA expressions. In conclusion, miR-222 may be new markers for stellate cell activation and liver fibrosis progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan : A hospital-based study of 1162 patients
日本大阪爱林区丙型肝炎病毒感染率高:一项针对 1162 名患者的医院研究
DOI: 10.1111/j.1872-034x.2011.00834.x
发表时间: 2011
期刊: Repatol Res
影响因子: --
作者: [Yamaguchi Y, Enomoto M, Fujii H, Tamori A, Sakaguchi H, Tanigawa T, Watanabe K, Fujiwara Y, Arakawa T, Harihara S, Monna T, Kawada N]
通讯作者: Kawada N
Genotype 1bのC型慢性肝炎に対するPEG-IFN-α/リバビリン投与期間の個別化について:リアルタイムPCRによるresponse-guided therapyの再評価
基因型 1b 慢性丙型肝炎的 PEG-IFN-α/利巴韦林给药周期个体化:使用实时 PCR 重新评估反应引导治疗
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [中屋美香, 榎本大, 林健博, 遠山まどか, 藤井英樹, 小林佐和子, 岩井秀司, 森川浩安, 田守昭博, 坂口浩樹, 羽生大記, 塩見進, 河田則文]
通讯作者: 河田則文
Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2
对丙型肝炎病毒基因型 2 病毒载量较高的慢性肝炎患者进行反应指导治疗
DOI: 10.1111/j.1872-034x.2011.00956.x
发表时间: 2012
期刊: Hepatol Res
影响因子: 4.2
作者: [Yamaguchi Y, Tamori A, Tanaka Y, Iwai S, Kobayashi S, Fujii H, Morikawa H, Hagihara A, Enomoto M, Kawada N]
通讯作者: Kawada N
Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis
枸橼酸莫沙必利对干扰素引起的胃轻瘫胃排空的影响
DOI: --
发表时间: 2012
期刊: Dig Dis Sci
影响因子: --
作者: [Kawamura E, Enomoto M, Kotani K, Hagihara A, Fujii H, Kobayashi S, Iwai S, Morikawa H, Kawabe J, Tominaga K, Tamori A, Shiomi S, Kawada N]
通讯作者: Kawada N
共 19 条
    Synthetic study of novel antibiotics derived from natural products using cluster effect
    Synthetic studies and SAR of the structurally complex indole diterpenes showing strong insecticidal activities
    Synthetic and SAR studies of alchivemycin, novel antibacterial and antitumor polyketide
    • 批准号:
      21880012
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $1.77万
    • 财政年份:
      2009
    • 负责人:
      ENOMOTO Masaru
    • 依托单位:
    海外基金